Submit Deal

Submit Deal

Cover Image CELLULAR BIOMEDICINE GROUP

CELLULAR BIOMEDICINE GROUP

CELLULAR BIOMEDICINE GROUP

Summary

Cellular Biomedicine Group operates as a biopharmaceutical company. The Company develops cell therapies for the treatment of cancer.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 296 M

Avg. Deal Size£ 148 M

Market Context

Senior Management

Tony Liu
CEO
Terry A. Belmont
Chairman
Derrick C. Li
Head of Strategy and Investor Relations

Sort

dc

derrick c. li

Head of Strategy and Investor Relations at CELLULAR BIOMEDICINE GROUP

Manager

1

Deal

£ 293 M

Total Value

tl

tony liu

CEO at CELLULAR BIOMEDICINE GROUP

Manager

1

Deal

£ 3 M

Total Value

ac

andrew chan

General Counsel at CELLULAR BIOMEDICINE GROUP

Manager

1

Deal

£ 293 M

Total Value

ta

terry a. belmont

Chairman at CELLULAR BIOMEDICINE GROUP

Manager

2

Deals

£ 296 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite